Invitae Corporation (NYSE:NVTA) shares are trading lower this Wednesday after the company reported fourth-quarter financial results and provided guidance for full-year 2023. The company also announced ...

Hi, everyone. Good afternoon. Thanks for joining us here. If you don't know me, my name is Andrew Brackmann, I cover diagnostics for William Blair. This afternoon, we have Invitae joining us. We have ...

Yes. Thank you. Great. We are just about at the time here 1:30. So sorry about that. Welcome. Obviously, day one of the TD Cowen Health Care Conference. I am Dan Brennan. One of the tools analyst here ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Invitae rolled up several ...

It's been a sad week for Invitae Corporation (NYSE:NVTA), who've watched their investment drop 12% to US$23.82 in the week since the company reported its full-year result. The results look positive ...

Invitae Corporation (NYSE: NVTA) is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people ...

Labcorp beats Q2 profit and revenue estimates on demand for health tests Labcorp beat Wall Street expectations for second-quarter profit and revenue on Thursday on strong demand for its diagnostic ...

We recently compiled a list of the 10 Best Stocks to Buy and Hold For 5 Years According to Cathie Wood. In this article, we are going to take a look at where Invitae Corporation (OTC:NVTAQ) stands ...

SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it will host an investor conference call on Wednesday, October 7 at 4:30 p.m.

SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it will report its fourth quarter and year-end 2015 financial results on Tuesday, ...